Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.5%

1 terminated out of 22 trials

Success Rate

90.0%

+3.4% vs benchmark

Late-Stage Pipeline

9%

2 trials in Phase 3/4

Results Transparency

0%

0 of 9 completed with results

Key Signals

90% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (6)
P 1 (2)
P 2 (5)
P 4 (2)

Trial Status

Completed9
Recruiting5
Not Yet Recruiting4
Withdrawn1
Terminated1
Enrolling By Invitation1

Trial Success Rate

90.0%

Benchmark: 86.6%

Based on 9 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT07856043Phase 1Not Yet Recruiting

[11C]PS13 PET Imaging of Neuroinflammation in Heart Failure With Reduced Ejection Fraction

NCT07644065Not ApplicableCompleted

Kynurenic Acid and Serotonin as Perioperative Neuroinflammatory Biomarkers in Sequential Third Molar Surgery

NCT06725719RecruitingPrimary

Translocator Protein PET/CT in Various TSPO-Related Disease

NCT05350774Phase 2Enrolling By Invitation

Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2

NCT07782411Not ApplicableNot Yet Recruiting

Effect of Tocopherol and Ascorbic Acid on Neuroinflammation Markers Associated With Neuropeptide Expression in the AgRP/NPY and POMC Pathways in Mexican Population With Obesity

NCT07671040Not ApplicableCompleted

A Pilot Study of Adjunctive Structured Supportive Psychotherapy in Schizophrenia

NCT07269457Phase 2Recruiting

Vitamin D3 for Moderate to Mild Traumatic Brain Injury: A Randomized Trial on Inflammation and Recovery (VIMOT)

NCT07575516Phase 2Completed

Effectiveness of Ashwagandha in Schizophrenia Patients on Risperidone

NCT04814355Phase 4Completed

The Effect of Celecoxib on Neuroinflammation in MDD

NCT06404203Not ApplicableCompleted

The Effect of Oral Use of Lyophilised Royal Jelly on Cognitive Functions and Immune System in Elderly Individuals

NCT05129514Not ApplicableTerminated

Imaging Lymphatic/Cerebrospinal Fluid (CSF) Drainage From the Head and Neck in Persons With Traumatic Brain Injury: Demonstration of Feasibility and Evaluation of Manual Therapy to Improve Drainage and Facilitate Cognitive Recovery

NCT07424001Phase 4Completed

Preemptive IV Ibuprofen for Neurocognitive Recovery and Analgesic Needs After Inguinal Hernia Surgery

NCT06718452Not ApplicableNot Yet Recruiting

Tinnitus and Treatment With umPEA-LUT

NCT07388160Not Yet Recruiting

Neuroinflammatory Biomarkers After General Anesthesia: A Comparison Study

NCT06322342Phase 2Completed

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

NCT06973837Recruiting

Studying the Neurobiological Mechanisms of Non-specific Chronic Low Back Pain and Chronic Insomnia: a Four-group Cross-sectional Study

NCT06432023RecruitingPrimary

Imaging - Clinical Evaluation of Altered Nervous System Drainage

NCT06391866RecruitingPrimary

Neuroinflammation/Oxidative Stress/Cardiac Surgery

NCT03058328CompletedPrimary

The White Blood Cell Reactivity Following Surgical Trauma and Associated Regulatory Mechanisms.

NCT04318626Phase 2Unknown

The Influence of [18F]PMPBB3 and [18F]THK5351 PET Distribution Patterns on Post-stroke Cognitive Impairment

Scroll to load more

Research Network

Activity Timeline